Publications

5674 Results

SWOG S1216: A phase III randomized trial comparing androgen deprivation therapy (ADT) plus TAK-700 with ADT plus bicalutamide in patients (pts) with newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC) (NCT01809691)

Authors
N Agarwal;C Tangen;MHA Hussain;S Gupta;M Plets;P Lara;A Harzstark;P Twardowski;C Paller;D Zylla;M Zibelman;E Levine;B Roth;A Goldkorn;D Vaena;M Kohli;A Crispino;N Vogelzang;IM Thompson;DI Quinn
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 5001) (American Society of Clinical Oncology Annual Meeting 2021, oral)
Year
2021
Research Committee(s)
Genitourinary
Study Number(s)
S1216

Final Analysis of Overall Survival (OS) and Relapse-Free-Survival (RFS) in the Intergroup S1404 Phase III Randomized Trial Comparing Either High Dose Interferon (HDI) or Ipilimumab to Pembrolizumab in Patients with High Risk Resected Melanoma

Authors
K Grossmann;M Othus;S Patel;A Tarhini;V Sondak;T Petrella;T-G Truong;N Khushalani;JV Cohen;E Buchbinder;K Kendra;P Funchain;K Lewis;B Chmielowski;H Li;J Moon;K Gunturu;Z Eroglu;JM Kirkwood;A Ribas
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 9501) (American Society of Clinical Oncology Annual Meeting 2021, oral)
Year
2021
Research Committee(s)
Melanoma
Study Number(s)
S1404

E1411 Randomized Phase 2 Trial of Bendamustine-Rituximab (BR)-Based Induction Followed By Rituximab (R) ± Lenalidomide (L) Consolidation for Mantle Cell Lymphoma: Addition of Bortezomib to Front-Line BR Induction does not prolong PFS

Authors
MR Smith;O Jegede;P Martin;B Till;S Parekh;D Yang;L Kostakoglu Shields;C Casulo;N Bartlett;P Caimi;T Al Baghdadi;K Maddocks;M Romer;D Inwards;R Lerner;L Wagner;R Little;J Friedberg;J Leonard;B Kahl
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 7503) (American Society of Clinical Oncology Annual Meeting 2021, oral)
Year
2021
Research Committee(s)
Lymphoma
Study Number(s)
CTSU/E1411

Dietary fat intake in relation to overall and progression-free survival among people with advanced or metastatic colorectal cancer: data from CALGB 80405

Authors
E Van Blarigan;C Ma;F-S Ou;A Venook;D Niedzwiecki;E Giovannucci;H-J Lenz;F Innocenti;J Shaw;B Polite;H Hochster;R Goldberg;R Mayer;CD Blanke;E O'Reilly;C Fuchs;J Meyerhardt
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 3588) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
Year
2021
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Granulomatous and sarcoid-like immune related adverse events (irAEs) in melanoma patients following CTLA4 blockade blockade adjuvant therapy: An analysis of 1670 high-risk patients

Authors
A Noor;I Nassine;S Lee;M Othus;J Moon;J Kirkwood;V Sondak;A Ribas;K Grossmann;A Tarhini
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 9582) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
Year
2021
Research Committee(s)
Melanoma
Study Number(s)
CTSU/E1609

Influence of dietary insulin scores on survival in patients with metastatic colorectal cancer (mCRC): Findings from CALGB (Alliance) 80405

Authors
K DiNardo;S Zhang;F-S Ou;C Yuan;B Guerico;V Morales-Oyarvide;E Van Blarigan;D Niedzwiecki;I-Wen Chang;H-J Lenz;CD Blanke;A Venook;R Mayer;C Fuchs;F Innocenti;A Nixon;R Goldberg;E O'Reilly;J Meyerhardt
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 3568) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
Year
2021
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Phase III Comparison of High Dose Once-Daily (QD) Thoracic Radiotherapy (TRT) with Standard Twice-Daily (BID) TRT in limited stage small cell lung cancer (LSCLC): CALGB 30610 (Alliance) / RTOG 0538

Authors
J Bogart;X Wang;G Masters;J Gao;R Komaki;L Gaspar;J Heymach;C Dobelbower;C Kuzma;T Stinchcombe;J Bradley;E Vokes
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 8505) (American Society of Clinical Oncology Annual Meeting 2021, oral)
Year
2021
Research Committee(s)
Lung

Association of Adiponectin with Tumor Infiltrating Lymphocytes in Patients with Stage III Colon Cancer Treated in an Adjuvant Chemotherapy Trial (NCCTG N0147, Alliance)

Authors
F Sinicrope;Q Shi;T Smyrk;R Goldberg;E Heying;S Cohen;S Gill;D Sha;Z Jin;M Kahlenberg;S Nair;A Shields;B Jahagirdar;N Foster;M Pollak;S Alberts
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr 3591) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
Year
2021
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/N0147

S1801: A randomized phase II trial of adjuvant versus neoadjuvant pembrolizumab (PEM) for melanoma

Authors
SP Patel;M Othus;J Moon;M Tetzlaff;E Buchbinder;VK Sondak;M Lowe;K Mireles;E Sharon;L Korde;S Guild;W Carson;A Ribas;K Grossmann
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr TPS9585) (American Society of Clinical Oncology Annual Meeting 2021 (TIPS poster)
Year
2021
Research Committee(s)
Melanoma
Study Number(s)
S1801

A Randomized Phase III Study of Immune Checkpoint Inhibition with Chemotherapy in Treatment-Naive Metastatic Anal Cancer Patients: A trial of the ECOG-ACRIN Cancer Research Group (EA2176)

Authors
M Roth;P Catalana;K Ciombor;A Benson;X Yao;R Yaeger;M Salem;V Morris;D Henry;J Whisenant;P O'Dwyer;C Eng
Journal / Conference
J Clin Oncol 39, 2021 (suppl 15; abstr TPS3614) (American Society of Clinical Oncology Annual Meeting 2021, poster session)
Year
2021
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/EA2176